Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization. (Q54297668)

27 May 2018

title

Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization. (English)

1 reference

27 May 2018

methicillin-resistant Staphylococcus aureus

main subject

0 references

Staphylococcus aureus

1 reference

Joan M Remy

1

1 reference

27 May 2018

Cheryl A Tow-Keogh

2

1 reference

27 May 2018

Timothy S McConnell

3

1 reference

27 May 2018

James M Dalton

4

1 reference

27 May 2018

Joseph A Devito

5

1 reference

27 May 2018

language of work or name

English

0 references

publication date

8 August 2012

1 reference

27 May 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

27 May 2018

volume

67

1 reference

27 May 2018

issue

12

1 reference

27 May 2018

page(s)

2814-2820

1 reference

27 May 2018

Systematic review: fluoroquinolones for the treatment of intra-abdominal surgical infections

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Development of the quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Complicated skin and soft tissue infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Gatifloxacin, Gemifloxacin, and Moxifloxacin: The Role of 3 Newer Fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Quinolones: action and resistance updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Staphylococcus aureus mutants selected by BMS-284756.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Mechanisms of action of antimicrobials: focus on fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS307

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS307

1 reference

27 May 2018

PubMed ID

22875850

1 reference

27 May 2018